BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4014441)

  • 1. Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.
    Ratech H; Greco MA; Gallo G; Rimoin DL; Kamino H; Hirschhorn R
    Am J Pathol; 1985 Jul; 120(1):157-69. PubMed ID: 4014441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroosseous histopathology in adenosine deaminase deficient combined immunodeficiency disease.
    Kaitila I; Rimoin DL; Cedarbaum SD; Stiehm ER; Lachman RS
    Birth Defects Orig Artic Ser; 1976; 12(6):115-21. PubMed ID: 974246
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations.
    Ratech H; Hirschhorn R; Greco MA
    Am J Pathol; 1989 Dec; 135(6):1145-56. PubMed ID: 2596574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential deoxyadenosine toxicity to immature rabbit cartilage in vitro. A model for the chondro-osseous dysplasia of adenosine deaminase deficiency.
    Wortmann RL; Veum JA; Ryan LM; Cheung HS
    Arthritis Rheum; 1989 Aug; 32(8):1014-21. PubMed ID: 2788422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
    Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
    J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency.
    Cederbaum SD; Kaitila I; Rimoin DL; Stiehm ER
    J Pediatr; 1976 Nov; 89(5):737-42. PubMed ID: 978320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
    Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH
    J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal platelet aggregation in severe combined immunodeficiency disease with adenosine deaminase deficiency.
    Schwartz AL; Polmar SH; Stern RC; Cowan DH
    Br J Haematol; 1978 Jun; 39(2):189-94. PubMed ID: 678472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
    Polmar SH
    Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
    Cowan MJ; Shannon KM; Wara DW; Ammann AJ
    Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
    Sawami H; Toyokawa Y; Ito K; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):721-9. PubMed ID: 2618547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother.
    Schmalstieg FC; Mills GC; Tsuda H; Goldman AS
    Pediatr Res; 1983 Dec; 17(12):935-40. PubMed ID: 6606796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe combined immunodeficiency with adenosine deaminase deficiency (author's transl)].
    Allepuz Llop N; Pellejá Pellejá J
    An Esp Pediatr; 1982 May; 16(5):421-5. PubMed ID: 7114620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical delineation of adenosine deaminase deficiency.
    Hirschhorn R
    Ciba Found Symp; 1978; (68):35-54. PubMed ID: 387358
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA
    Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenosine deaminase activity and immune dysfunction (author's transl)].
    Bremer H; Bauer I; Brock J
    Allerg Immunol (Leipz); 1981; 27(1):3-13. PubMed ID: 6455054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family study on the kindred of an adenosine deaminase deficient child with severe combined immunodeficiency.
    Lee CH; Ziegler JB; Rozenberg MC
    Aust N Z J Med; 1979 Oct; 9(5):530-3. PubMed ID: 294907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine dysfunction in cells from patients with adenosine deaminase deficiency.
    Benke PJ; Dittmar D
    Pediatr Res; 1976 Jul; 10(7):642-6. PubMed ID: 132630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis for adenosine deaminase deficiency.
    Ziegler JB; Van der Weyden MB; Lee CH; Daniel A
    J Med Genet; 1981 Apr; 18(2):154-6. PubMed ID: 7241535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein.
    Valerio D; Duyvesteyn MG; van Ormondt H; Meera Khan P; van der Eb AJ
    Nucleic Acids Res; 1984 Jan; 12(2):1015-24. PubMed ID: 6198631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.